Sawai Pharmaceutical Co., Ltd. et al. vs. Astellas Pharma Inc.
Explore the PTAB proceeding IPR2018-00079 filed by Sawai Pharmaceutical Co., Ltd. et al. on 2017-10-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-00079
Filing Date
2017-10-16
Accorded Filing Date
2017-10-16
Institution Decision Date
2018-05-04
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
β
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Sawai Pharmaceutical Co., Ltd. et al.
Represented By
Sodikoff, Brian et alPatent Owner / Respondent
Astellas Pharma Inc.
Represented By
Baechtold, Robert et alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,346,532 Asserted | Asserted Patent | View Official Patent → |
| π―π΅ Japan | JP 28577897 | Japan Counterpart | View Official Patent → |
| π PCT International (WIPO) | WO 1999020607 A1 | PCT World Application | View Official Patent → |
Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd.
Astellas Pharma Inc. v. Actavis Elizabeth LLC